BIOMAT Database Logo BIOMAT Database Logo

Cholinesterase inhibition and toxicokinetics in immature and adult rats after acute or repeated exposures to chlorpyrifos or chlorpyrifos-oxon. 2012

M S Marty, and A K Andrus, and M P Bell, and J K Passage, and A W Perala, and K A Brzak, and M J Bartels, and M J Beck, and D R Juberg
Toxicology & Environmental Research and Consulting, The Dow Chemical Company, 1803 Building, Midland, MI 48674, USA. mmarty@dow.com

The effect of age or dose regimen on cholinesterase inhibition (ChEI) from chlorpyrifos (CPF) or CPF-oxon (CPFO) was studied in Crl:CD(SD) rats. Rats were exposed to CPF by gavage in corn oil, rat milk (pups), or in the diet (adults) or to CPFO by gavage in corn oil. Blood CPF/CPFO levels were measured. With acute exposure, ChEI NOELs were 2 mg/kg CPF for brain and 0.5 mg/kg CPF for red blood cells (RBCs) in both age groups. In pups, ChEI and blood CPF levels were similar using either milk or corn oil vehicles. Compared to gavage, adults given dietary CPF (12 h exposure) had greater RBC ChEI, but lower brain ChEI at corresponding CPF doses, indicating an effect of dose rate. With repeated CPF exposures, ChEI NOELs were the same across ages (0.5 and 0.1 mg/kg/day for brain and RBCs, respectively). With CPFO dosing, the ChEI NOELs were 0.1 mg/kg (acute) and 0.01 mg/kg/day (repeated doses) for RBCs with no ChEI in brain at CPFO doses up to 0.5 (pup) or 10 mg/kg (adult) for acute dosing or 0.5 mg/kg/day for both ages with repeat dosing. Thus, there were no age-dependent differences in CPF ChEI via acute or repeated exposures. Pups had less ChEI than adults at comparable blood CPF levels. Oral CPFO resulted in substantial RBC ChEI, but no brain ChEI, indicating no CPFO systemic bioavailability to peripheral tissues.

UI MeSH Term Description Entries
D007306 Insecticides Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. Insecticide
D008297 Male Males
D009043 Motor Activity Body movements of a human or an animal as a behavioral phenomenon. Activities, Motor,Activity, Motor,Motor Activities
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D002800 Cholinesterase Inhibitors Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system. Acetylcholinesterase Inhibitor,Acetylcholinesterase Inhibitors,Anti-Cholinesterase,Anticholinesterase,Anticholinesterase Agent,Anticholinesterase Agents,Anticholinesterase Drug,Cholinesterase Inhibitor,Anti-Cholinesterases,Anticholinesterase Drugs,Anticholinesterases,Cholinesterase Inhibitors, Irreversible,Cholinesterase Inhibitors, Reversible,Agent, Anticholinesterase,Agents, Anticholinesterase,Anti Cholinesterase,Anti Cholinesterases,Drug, Anticholinesterase,Drugs, Anticholinesterase,Inhibitor, Acetylcholinesterase,Inhibitor, Cholinesterase,Inhibitors, Acetylcholinesterase,Inhibitors, Cholinesterase,Inhibitors, Irreversible Cholinesterase,Inhibitors, Reversible Cholinesterase,Irreversible Cholinesterase Inhibitors,Reversible Cholinesterase Inhibitors
D002802 Cholinesterases Acylcholineacylhydrolase,Cholase,Cholinesterase
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004390 Chlorpyrifos An organothiophosphate cholinesterase inhibitor that is used as an insecticide and as an acaricide. Dursban,Lorsban
D004912 Erythrocytes Red blood cells. Mature erythrocytes are non-nucleated, biconcave disks containing HEMOGLOBIN whose function is to transport OXYGEN. Blood Cells, Red,Blood Corpuscles, Red,Red Blood Cells,Red Blood Corpuscles,Blood Cell, Red,Blood Corpuscle, Red,Erythrocyte,Red Blood Cell,Red Blood Corpuscle
D005260 Female Females

Related Publications

M S Marty, and A K Andrus, and M P Bell, and J K Passage, and A W Perala, and K A Brzak, and M J Bartels, and M J Beck, and D R Juberg
Age-related brain cholinesterase inhibition kinetics following in vitro incubation with chlorpyrifos-oxon and diazinon-oxon.
January 2007, Toxicological sciences : an official journal of the Society of Toxicology,
M S Marty, and A K Andrus, and M P Bell, and J K Passage, and A W Perala, and K A Brzak, and M J Bartels, and M J Beck, and D R Juberg
Comparative neurochemical effects of repeated methyl parathion or chlorpyrifos exposures in neonatal and adult rats.
July 1999, Toxicology and applied pharmacology,
M S Marty, and A K Andrus, and M P Bell, and J K Passage, and A W Perala, and K A Brzak, and M J Bartels, and M J Beck, and D R Juberg
Re: age-related brain cholinesterase inhibition kinetics following in vitro incubation with chlorpyrifos-oxon and diazinon-oxon.
August 2007, Toxicological sciences : an official journal of the Society of Toxicology,
M S Marty, and A K Andrus, and M P Bell, and J K Passage, and A W Perala, and K A Brzak, and M J Bartels, and M J Beck, and D R Juberg
Binary mixtures of azinphos-methyl oxon and chlorpyrifos oxon produce in vitro synergistic cholinesterase inhibition in Planorbarius corneus.
July 2012, Chemosphere,
M S Marty, and A K Andrus, and M P Bell, and J K Passage, and A W Perala, and K A Brzak, and M J Bartels, and M J Beck, and D R Juberg
Analysis of the additivity of in vitro inhibition of cholinesterase by mixtures of chlorpyrifos-oxon and azinphos-methyl-oxon.
April 2001, Toxicology and applied pharmacology,
M S Marty, and A K Andrus, and M P Bell, and J K Passage, and A W Perala, and K A Brzak, and M J Bartels, and M J Beck, and D R Juberg
Comparative neurochemical and neurobehavioral effects of repeated chlorpyrifos exposures in young and adult rats.
September 1993, Pharmacology, biochemistry, and behavior,
M S Marty, and A K Andrus, and M P Bell, and J K Passage, and A W Perala, and K A Brzak, and M J Bartels, and M J Beck, and D R Juberg
Cholinesterase inhibition and alterations of hepatic metabolism by oral acute and repeated chlorpyrifos administration to mice.
May 2007, Toxicology,
M S Marty, and A K Andrus, and M P Bell, and J K Passage, and A W Perala, and K A Brzak, and M J Bartels, and M J Beck, and D R Juberg
Acetylcholinesterase inhibition dose-response modeling for chlorpyrifos and chlorpyrifos-oxon.
June 2012, Regulatory toxicology and pharmacology : RTP,
M S Marty, and A K Andrus, and M P Bell, and J K Passage, and A W Perala, and K A Brzak, and M J Bartels, and M J Beck, and D R Juberg
Repeated inhibition of cholinesterase by chlorpyrifos in rats: behavioral, neurochemical and pharmacological indices of tolerance.
July 1994, The Journal of pharmacology and experimental therapeutics,
M S Marty, and A K Andrus, and M P Bell, and J K Passage, and A W Perala, and K A Brzak, and M J Bartels, and M J Beck, and D R Juberg
Behavioral and neurochemical effects of acute chlorpyrifos in rats: tolerance to prolonged inhibition of cholinesterase.
August 1993, The Journal of pharmacology and experimental therapeutics,
Copied contents to your clipboard!